載入...
Cancer-targeted therapies and radiopharmaceuticals
The treatment of bone metastases remains a clinical challenge. Although a number of well-established agents, namely bisphosphonates and denosumab, are available to reduce the occurrence of skeletal-related events, additional cancer-targeted therapies are required to improve patients' prognosis...
Na minha lista:
| 發表在: | Bonekey Rep |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455688/ https://ncbi.nlm.nih.gov/pubmed/26131359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2015.76 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|